drugset / Trial / NCT05847660
Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient
RandomizedParallel-groupOpen-labelTreatment
Summary
this study is designed to compare the Progesterone primed ovarian stimulation protocol versus the antagonist protocol as a method to stimulate PCO patients in ICSI cycles to decrease cost and decrease OHSS.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2024-06-01
- Completion
- 2024-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cetrorelix | Other / unclassified | 0.25 mg | Subcutaneous |
| Comparator | Dydrogesterone | Other / unclassified | 30 mg | Oral |